Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of administration methods of remimazolam during anesthesia induction in gynecologic day surgery
ChiCTR2600122398Phase 4Recruiting
- Sponsor
- Weifang People's Hospital
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam (2 arms), sponsored by Weifang People's Hospital. Primary endpoint: Success rate of anesthesia. Started Apr 2026; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2600122398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122398.